World Pharma News - Trial Date Set For SEROQUELŽ Patent Litigation

Home News Channels Contact Us Search XING Forums Members Login

Conferences & Events Be at Med-e-Tel 2009 to Meet a Highly Qualified eHealth Audience 4th Annual eMarketing Summit Europe 2009 2nd Annual Global Business Intelligence Summit How to Implement Risk Management Principles and Activities Within a Quality Management System	Research & Development PharmaNews.eu - Dynamic European Pharmaceutical News Engine Healthcare Costs Prevented Almost 40 Million Americans from Filling Their Prescriptions in 2008 New semantics in GoPubMed and European biotech start-ups Metabolic disturbances indicate progress of the disease even years in advance
Read more...	Read more...

Welcome

World Pharma News is an ambitious online news service dedicated to the world pharmaceutical industry. Our main goal is to keep our readers informed about the latest worldwide pharmaceutical news, realizations and achievements.

Register now to be in touch with our last developments and achievements or Subscribe to World Pharma News alerts by Email (a free e-mail delivery powered by Google).

Non progredi est regredi.

PharmaNews.eu, an advanced web based news project, targeting the European pharmaceutical domain, has been launched. The project was developed to directly connect, promote and disseminate the European pharmaceutical achievements...
For further information, please visit http://www.pharmanews.eu

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

Pharmaceutical RSS News

Start your day with worldwide pharmaceutical

European Commission - Pharmaceuticals
FDA

US Food and Drug Administration

Get all news digests delivered to your inbox, subscribe to World Pharma News Google Group.

Email:

World Pharma News .net / Published News

Sponsored Ads

Trial Date Set For SEROQUELŽ Patent Litigation

Thursday, 13 March 2008

AstraZeneca announced a trial date has been set for patent litigation in the US District Court for the District of New Jersey against Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs).

The ANDAs seek approval to market generic versions of SEROQUELŽ (quetiapine fumarate tablets) in the US before SEROQUEL's patent expires in 2011. The Court has set a date for trial beginning on 11 August 2008.

About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $29.55 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

For more information about AstraZeneca, please visit www.astrazeneca.com.

Bookmark with:

< Prev		Next >

[ Back ]

Sponsored Ads

Product U.S. Patent and Trademark Office Accepts Pfizer's Reissue Application on Lipitor FDA Approves Drug for Patients with Advanced Prostate Cancer Glivec shows significant benefit for gastrointestinal stromal tumor (GIST) patients First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management Roche and Axiogenesis Enter into Co-Development and Marketing Agreement	Clinical Trials Tarceva brings new hope to patients with advanced non-small cell lung cancer Bayer's XareltoŽ Shows Encouraging Results in Patients with Acute Coronary Syndrome CRESTORŽ is in line with other marketed statins - new data from the JUPITER study Early data show potential for imatinib to treat life-threatening form of pulmonary artery disease Bayer Reports Progress in Clinical Program for Riociguat	Corporate GlaxoSmithKline to cease providing corporate political contributions AstraZeneca and Bristol-Myers Squibb Announce Expansion of Worldwide Collaboration Children in the world's poorest countries to get free insulin AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva GSK and Neptunus form joint venture for the co-development of flu vaccines	Financial Novo Nordisk and VLST Corporation announce collaboration agreement AstraZeneca and MAP Pharmaceuticals Announce Worldwide Collaboration Roche signs definitive agreement to acquire Memory Pharmaceuticals Johnson & Johnson Announces Definitive Agreement to Acquire Omrix AstraZeneca to divest Nordic over-the-counter portfolio
Read more...	Read more...	Read more...	Read more...

Conferences & Events

Research & Development

Welcome

Pharmaceutical Companies

Sponsored Ads

Pharmaceutical RSS News

World Pharma News .net / Published News

Sponsored Ads

Most Read - Product

Sponsored Ads

Product

Clinical Trials

Corporate

Financial